Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Imatinib mesylate

First report of periorbital oedema: case report

    • 16 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Imatinib mesylate. React. Wkly. 920, 8–9 (2002). https://doi.org/10.2165/00128415-200209200-00021

    Download citation

    Keywords

    • Imatinib
    • Chronic Myelogenous Leukaemia
    • Myelogenous Leukaemia
    • Imatinib Mesylate
    • Lower Eyelid